Historical Foundations and the Legislative Intent of Section 41

Congress introduced the research credit through the Economic Recovery Tax Act of 1981 to encourage additional research investment. The credit was temporary and underwent repeated extensions before the Protecting Americans from Tax Hikes Act of 2015 made it permanent.

The regular research credit is incremental: it generally measures qualified research expenses against a statutory base amount. Gross receipts affect that calculation, which explains their importance in the P&G litigation. The alternative simplified credit uses a different expense-based comparison and does not use gross receipts to calculate its research-expense threshold. Neither method establishes that every credited dollar represents research that would otherwise not have occurred.

The Statutory Architecture: The Four-Part Test and Eligible Expenses

Research must satisfy the four-part test, applied separately to each business component, as well as the statutory exclusions and expense rules. A business component can be a product, process, computer software, technique, formula, or invention. Where a whole component fails, the regulatory shrinking-back rule may permit examination of an appropriate subset.

Section 41(b) QREs comprise qualifying in-house research expenses and contract research expenses. In-house categories include wages for qualified services, supplies used in qualified research, and eligible payments for the right to use computers in qualified research. Generally, 65% of eligible contract research payments enters QREs, subject to statutory exceptions. Basic research payments have a separate credit computation under Sections 41(a)(2) and 41(e); they are not simply a fourth QRE category. Taxpayers must substantiate the nature and amount of eligible expenses and their connection to qualified activities.

Detailed Analysis of Procter & Gamble Co. v. United States (2010)

The 2010 litigation involving the Procter & Gamble Company (P&G) centered on a sophisticated legal question: whether a taxpayer must include receipts from intercompany transactions with foreign members of its “controlled group of corporations” when determining its “Gross Receipts” for the purpose of the research credit calculation.

Factual Background and Audit Controversy

P&G, a diversified global manufacturer of consumer products including brands such as Tide, Crest, and Pampers, operates through a vast network of domestic and international subsidiaries. In the ordinary course of business, these subsidiaries engage in extensive intercompany transfers. For the tax years 2001 through 2005, P&G claimed research credits using a methodology that treated all members of its controlled group as a “single taxpayer” pursuant to Section 41(f).

Under this single-taxpayer approach, P&G excluded receipts from intercompany sales—both domestic and foreign—from its calculation of gross receipts. This practice was consistent with P&G’s historical filings and was initially approved by the IRS during an audit. However, in 2006, the IRS Office of Chief Counsel revised its position (CCA 200620023), asserting that receipts from foreign subsidiaries must be included in gross receipts, even while domestic intercompany receipts remained excluded.

The Core Dispute and Legal Arguments

The IRS recomputation included foreign intercompany receipts in average annual gross receipts, increasing P&G’s base amount and reducing its research credit. The government relied on its interpretation of the statute and regulations to distinguish gross receipts from research expenditures and foreign subsidiaries from domestic subsidiaries.

P&G relied on Section 41(f)(1)(A)(i), which treats controlled-group members as a single taxpayer. It argued that internal transactions should therefore be eliminated when computing group gross receipts, including transactions with foreign group members. P&G also maintained that counting those transfers would distort the credit’s measurement of research relative to receipts.

The District Court’s Judicial Reasoning

The U.S. District Court for the Southern District of Ohio granted partial summary judgment in favor of P&G. The court rejected the IRS’s bifurcated treatment of domestic and foreign subsidiaries, emphasizing several key legal principles:

Statutory Consistency: The court applied the single-taxpayer rule to the research-credit computation, including the disputed gross receipts.

Controlled-Group Scope: The statutory controlled-group definition did not support the government’s proposed exclusion of foreign corporate members from single-taxpayer treatment.

Purpose of the Credit: The court considered the exclusion of internal transactions consistent with the credit’s intended measurement and rejected the government’s treatment of foreign intercompany receipts.

The court granted P&G partial summary judgment on the gross-receipts issue and denied the government’s cross-motion. The holding concerns receipts from transactions within the controlled group; it does not establish that all foreign receipts or all foreign research costs are excluded or eligible on the same basis.

The “Single Taxpayer” Doctrine and Controlled Group Computations

Section 41(f) requires controlled corporations and specified businesses under common control to compute the credit as a single taxpayer. P&G illustrates the importance of that aggregation rule for intercompany receipts. Under current rules, the group credit is allocated by each member’s proportionate share of aggregate QREs. The applicable allocation rules must be checked for the tax year concerned, rather than assuming today’s method governed every historical year.

Mathematical Implications of Gross Receipts

For the regular credit’s QRE component, the simplified formulas below incorporate the minimum base amount. They exclude separate basic-research and energy-research credit components and precede any Section 280C reduced-credit election or general business credit limitation.

Base amount = greater of (fixed-base percentage × average annual gross receipts for the four preceding tax years) or (50% × current-year QREs).

Regular QRE credit = 20% × max(0, current-year QREs − base amount). The fixed-base percentage is subject to statutory historical-period or startup rules and a 16% cap.

In P&G, adding foreign intercompany sales to average annual gross receipts increased the base amount and reduced the credit. More generally, the overall effect of changing gross receipts depends on both the fixed-base percentage and the four-year receipts average, as well as the 50% minimum base. Consistent treatment across the applicable periods is essential; an exclusion does not necessarily increase every taxpayer’s credit.

Comparative Analysis with Contemporary Case Law

P&G addresses credit computation, whereas other research-credit cases address whether particular activities and costs qualify. These are distinct questions: a taxpayer can use the correct group calculation and still fail to substantiate its underlying research expenses.

Union Carbide and Production Supply Costs

In Union Carbide Corp. v. Commissioner, T.C. Memo. 2009-50, affirmed at 697 F.3d 104 (2d Cir. 2012), the taxpayer sought credits for raw materials used in production runs during process experiments. The courts rejected treating ordinary production costs that would have been incurred without the research as qualified supplies merely because research occurred during production. The decision should not be reduced to a universal rule disqualifying any supply connected with goods ultimately sold. The relevant inquiry concerns the relationship of the claimed expense to qualified research and the specific facts.

Trinity Industries and the Substantially All Test

Trinity Industries, Inc. v. United States involved research-credit claims for ship development, with decisions in 2010 and on appeal in 2014. The substantially-all requirement generally means that at least 80% of the relevant research activities, measured on a cost or other consistently applied reasonable basis, constitute elements of a qualifying process of experimentation. Meeting that threshold does not automatically make every project cost a QRE: expense-category rules and exclusions still apply. Little Sandy Coal Co. v. Commissioner, T.C. Memo. 2021-15, affirmed at 62 F.4th 287 (7th Cir. 2023), emphasizes proof of experimental activities rather than reliance on a vessel’s novelty. Phoenix Design Group, Inc. v. Commissioner, T.C. Memo. 2024-113, likewise illustrates the importance of establishing the statutory research requirements.

Deere v. Commissioner: Foreign Branches vs. Subsidiaries

In Deere & Co. v. Commissioner, 133 T.C. 246 (2009), the Tax Court required inclusion of receipts from Deere’s foreign branches in the gross-receipts calculation for the then-available alternative incremental research credit. That case concerns the domestic corporation’s own foreign-branch receipts. P&G concerns elimination of transactions between controlled-group members. Deere preceded P&G and did not distinguish subsidiaries by referring to that later ruling. Neither case makes all foreign-related receipts interchangeable.

Documentation, Substantiation, and the Burden of Proof

Taxpayers must substantiate eligibility and the amount of their research credit. Recent disputes illustrate the consequences of evidence that fails to connect specific uncertainty, experimental activities, and claimed costs. These obligations should not be described as a newly created universal documentation standard or an automatic shift in the burden of proof.

Limits of Departmental Estimates

Departmental labels, surveys, and retrospective estimates do not by themselves establish qualified research. Betz v. Commissioner, T.C. Memo. 2023-84, and Phoenix Design Group illustrate failures to prove the underlying research requirements, not merely failures to maintain a particular timesheet format. Routine engineering calculations or a project’s complexity do not alone establish experimentation. Relevant design records, testing results, credible testimony, and defensible cost allocations can help substantiate a claim; the regulations do not mandate one exclusive form of contemporaneous project timekeeping.

The Evolution of IRS Form 6765

Form 6765 has progressed beyond the June 2024 draft described in the original study. The December 2025 instructions for the January 2025 form revision state that Section G is optional for tax years beginning before 2026 and required for years beginning after 2025, subject to exceptions. The form includes:

Business-component identification and expense information in Section G when applicable, using the instructions’ coverage and aggregation rules rather than an unconditional requirement to detail every component.

Identification in Section E of officer wages included in claimed qualified-service wages.

A QRE category summary and additional information about business components and changes in claimed expenses. Section G exceptions and separate amended-claim requirements must be evaluated under the applicable instructions.

The revised form increases the information requested with a claim but does not replace the substantive qualification and recordkeeping rules.

The TCJA, Section 174, and the Introduction of Section 174A

Research-expense deduction rules changed materially both in 2022 and in 2025. A current analysis must distinguish the TCJA capitalization period from the domestic expensing rules introduced by Public Law 119-21.

Capitalization and Restored Domestic Expensing

Before 2022, Section 174 generally permitted an election to deduct qualifying research expenses currently. For tax years beginning in 2022 through 2024, the TCJA generally required five-year amortization for domestic specified research expenditures and fifteen-year amortization for foreign expenditures, using a midpoint convention. For tax years beginning after December 31, 2024, new Section 174A generally permits current deduction of domestic research or experimental expenditures, with an alternative capitalization election. Foreign research expenditures remain subject to fifteen-year amortization under Section 174.

Interaction Among Sections 174, 174A, and 41

The research-expense deduction and research credit overlap but are not coextensive. For years beginning after 2024, Section 41(d)(1)(A) refers to domestic research or experimental expenditures under Section 174A, and the credit imposes additional qualification and expense limits. Research performed outside the United States, Puerto Rico, and U.S. possessions is excluded from qualified research under Section 41. An adjustment to a deduction can affect the credit, but does not invariably do so. Section 280C also coordinates research deductions and credits to prevent a double benefit.

Public Law 119-21 was enacted on July 4, 2025. In addition to restoring domestic expensing, it allows eligible small businesses to elect retroactive application for tax years beginning in 2022 through 2024, subject to eligibility, procedures, and deadlines. Other transition provisions allow recovery of remaining unamortized domestic expenditures in the first tax year beginning after 2024 or ratably over that year and the next. These provisions do not create blanket retroactive relief for every taxpayer or for foreign research expenditures.

Broader Implications of P&G’s Litigation Strategy

P&G has also litigated international tax disputes involving Section 482 allocations and foreign tax credits. Those cases provide useful comparisons, but they concern different statutes and do not establish a single general rule governing all international tax issues.

The Blocked Income Doctrine and Section 482

In Procter & Gamble Co. v. Commissioner, 961 F.2d 1255 (6th Cir. 1992), the Sixth Circuit affirmed a decision rejecting a Section 482 royalty-income allocation involving a Spanish subsidiary that was legally prohibited from paying the royalties. The result depended on the foreign legal restrictions and the governing Section 482 framework.

The blocked-income and research-credit decisions each constrained the IRS’s position under the provisions at issue. They should not be characterized as a general j